Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SRI-81 Shatavari Receives Health Canada Natural Product License - Nutraceuticals World

What are you searching for?

Sign in
Products & Ingredients

SRI-81 Shatavari Receives Health Canada Natural Product License

The approval comes with authorized health claims related to menopausal symptoms in women.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: wasanajai | Adobe Stock

CK Nutraceuticals, the exclusive Canadian distributor of Ixoreal Biomed’s SRI-81 Shatavari, announced that the ingredient has been issued a Natural Product Number (NPN80149608) by Health Canada.

The product license authorizes several health claims for SRI-81, including:

  • Helps manage menopausal symptoms.
  • Helps relieve vasomotor symptoms in perimenopausal women, such as hot flashes and night sweats.
  • Helps reduce menopausal symptoms such as anxiety, irritability, and fatigue.
  • Helps relieve symptoms of menopause to support and maintain overall well-being and quality of life in women.
  • Helps support healthy sexual arousal and satisfaction in women.

SRI-81 Shatavari is the latest offering from Ixoreal; its KSM-66 Ashwagandha has 14 Health Canada claims approvals. SRI-81 is a proprietary shatavari root extract clinically studied for women’s health, menopause support, and sexual wellness. The ingredient is standardized to shatavarin IV and total shatavarins.

“The Health Canada approval represents an important milestone for SRI-81 Shatavari and provides Canadian supplement brands with a compliant pathway to formulate innovative women’s health products backed by both clinical research and regulatory approval,” said Colleen Madden, VP of innovation at CK Nutraceuticals.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics